COVID-19 and diabetes: What does the clinician need to know?

被引:37
作者
Papadokostaki, Eleni [1 ]
Tentolouris, Nikolaos [2 ]
Liberopoulos, Evangelos [3 ]
机构
[1] Gen Hosp Heraklion Venizeleio Pananeio, Dept Med, Iraklion 71409, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Med Sch,Diabet Ctr, Athens, Greece
[3] Univ Ioannina, Fac Med, Dept Med, Ioannina 45110, Greece
关键词
SARS-CoV-2; COVID-19; Diabetes mellitus; MORTALITY; MELLITUS; OUTCOMES; RISK; COMORBIDITIES; SEVERITY;
D O I
10.1016/j.pcd.2020.06.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
COVID-19 and diabetes are currently two global pandemics. Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19. This review aims to summarize currently available data about prevalence, possible pathophysiological mechanisms and management of patients with diabetes and COVID-19. (C) 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:558 / 563
页数:6
相关论文
共 57 条
[1]   The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies [J].
Abu-Ashour, Waseem ;
Twells, Laurie ;
Valcour, James ;
Randell, Amy ;
Donnan, Jennifer ;
Howse, Patricia ;
Gamble, John-Michael .
BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
[2]   Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection [J].
Allard, Robert ;
Leclerc, Pascale ;
Tremblay, Claude ;
Tannenbaum, Terry-Nan .
DIABETES CARE, 2010, 33 (07) :1491-1493
[3]   Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2020 [J].
不详 .
DIABETES CARE, 2020, 43 :S193-S202
[4]  
[Anonymous], 2020, DIABETES CARE, DOI DOI 10.2337/6200682,DC200682
[5]   Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis [J].
Badawi, Alaa ;
Ryoo, Seung Gwan .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 49 :129-133
[6]   Diabetes and the risk of infection-related mortality in the US [J].
Bertoni, AG ;
Saydah, S ;
Brancati, FL .
DIABETES CARE, 2001, 24 (06) :1044-1049
[7]   Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States [J].
Bode, Bruce ;
Garrett, Valerie ;
Messler, Jordan ;
McFarland, Raymie ;
Crowe, Jennifer ;
Booth, Robby ;
Klonoff, David C. .
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (04) :813-821
[8]  
Bornstein S.R., 2020, LANCET DIABETES ENDO, DOI [10.1016/52213-858 /(20)30152-2, DOI 10.1016/52213-858/(20)30152-2.]
[9]   Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China [J].
Cai, Qingxian ;
Chen, Fengjuan ;
Wang, Tao ;
Luo, Fang ;
Liu, Xiaohui ;
Wu, Qikai ;
He, Qing ;
Wang, Zhaoqin ;
Liu, Yingxia ;
Liu, Lei ;
Chen, Jun ;
Xu, Lin .
DIABETES CARE, 2020, 43 (07) :1392-1398
[10]   Diabetes mellitus - A hypercoagulable state [J].
Carr, ME .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (01) :44-54